Clinical characteristics of heavy and non-heavy smokers with schizophrenia

Schizophrenia Research

Volumn 138, Issue 2-3, 2012, Pages 285-289

  Wehring, Heidi J ^a   Liu, Fang ^a   McMahon, Robert P ^a   Mackowick, Kristen M ^a   Love, Raymond C ^b   Dixon, Lisa ^a   Kelly, Deanna L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Cigarettes; Heavy; Schizophrenia; Smoking; Tobacco

Indexed keywords

COCAINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL FEATURE; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING CESSATION; TREATMENT PLANNING;

ADULT; COMORBIDITY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84862146444     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.03.024     Document Type: Article

References (58)

1. Anda F.R., Williamson D.R., Escobedo L.G., Mast E.E., Giovino G.A., Remington P.L. Depression and the dynamics of smoking. A national perspective. JAMA 1990, 264:1541-1545.
2. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. Morb. Mortal. Wkly. Rep. 2002, 51(14):300-303.
3. Baker A., Richmond R., Haile M., Lewin T.J., Carr V.J., Taylor R.L., Jansons S., Wilhelm K. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am. J. Psychiatry 2006, 163:1394-1942.
4. Baker A., Richmond R., Haile M., Lewin T.J., Carr V.J., Taylor R.L., Constable P.M., Jansons S., Wilhelm K., Moeller-Saxone K. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res. 2007, 150:141-152.
5. Bjartveit K., Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob. Control 2005, 14(5):315-320.
6. Bobes J., Arango C., Garcia-Garcia M., Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr. Res. 2010, 119:101-109.
7. Chapman S., Ragg M., McGeechan K. Citation bias in reported smoking prevalence in people with schizophrenia. Aust. N. Z. J. Psychiatry 2009, 43:277-282.
8. Cigarette smoking among adults-United States. Morb. Mortal. Wkly. Rep. 2007, 57(45):1221-1226. 2008.
9. Coughlin S.S., Calle E.E., Patel A.V., Thun M.J. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000, 11(10):915-923.
10. Craig W.Y., Palomaki G.E., Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784-788.
11. Criqui M.H., Wallace R.B., Heiss G., Mishkel M., Schonfeld G., Jones G.T. Cigarette smoking and plasma high-density lipoprotein cholesterol. the lipid research clinics program prevalence study. Circulation 1980, 2:IV70-6.
12. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76(2-3):135-157.
13. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 1995, 152:453-455.
14. de Leon J., Susce M.T., Diaz F.J., Rendon D.M., Velasquez D.M. Variables associated with alcohol, drug and daily smoking cessation in patients with severe mental illness. J. Clin. Psychiatry 2005, 66:1447-1455.
15. De Stefani E., Boffetta P., Oreggia F., Mendilaharsu M., Deneo-Pellegrini H. Smoking patterns and cancer of the oral cavity and pharynx: a case-control study in Uruguay. Oral Oncol. 1998, 34(5):340-346.
16. Degenhardt L., Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tob. Res. 2001, 3(3):225-234.
17. Diaz F.J., Rendon D.M., Velásquez D.M., Susce M.T., de Leon J. Datapoints: smoking and smoking cessation among persons with severe mental illnesses. Psychiatr. Serv. 2006, 57(4):462.
18. Dixon L., Medoff D.R., Wohlheiter K., DiClemente C., Goldberg R., Kreyenbuhl J., Adams C., Lucksted A., Davin C. Correlates of severity of smoking among persons with severe mental illness. Am. J. Addict. 2007, 16(2):101-110.
19. Dixon L.B., Medoff D., Goldberg R., Lucksted A., Kreyenbuhl J., DiClemente C., Potts W., Leith J., Brown C., Adams C., Afful J. Is implementation of the 5 A's of smoking cessation at community mental health centers effective for reduction of smoking by patients with serious mental illness?. Am. J. Addict. 2009, 18(5):386-392.
20. George T.P., Vessicchio J.C., Sacco K.A., Weinberger A.H., Dudas M.M., Allen T.M., Creeden C.L., Potenza M.N., Feingold A., Jatlow P.I. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol. Psychiatry 2008, 63:1092-1096.
21. Godtfredsen N.S., Prescott E., Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005, 294(12):1505-1510.
22. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 1992, 149(9):1189-1194.
23. Hatsukami D.K., Kotlyar M., Allen S., Jensen J., Li S., Le C., Murphy S. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 2005, 128(4):2528-2537.
24. Haustein K.O., Krause J., Haustein H., Rasmussen T., Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int. J. Clin. Pharmacol. Ther. 2004, 42(2):83-92.
25. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150(6):1115-1121.
26. Hitsman B., Spring B., Wolf W., Pingitore R., Crayton J.W., Hedeker D. Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls. Neuropsychopharmacology 2005, 30:640-648.
27. Hughes J.R., Carpenter M.J. The feasibility of smoking reduction: an update. Addiction 2005, 100(8):1074-1089.
28. Husten C.G. How should we define light or intermittent smoking? Does it matter?. Nicotine Tob. Res. 2009, 11(2):111-121.
29. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 1971, 74:1-12.
30. Kelly C., McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 1999, 156:1751-1757.
31. Kelly D.L., McMahon R.P., Wehring H.J., Liu F., Mackowick K.M., Boggs D.L., Warren K.R., Feldman S., Shim J.C., Love R.C., Dixon L. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr. Bull. 2011, 37(4):832-838.
32. Kelly D.L., Raley H.G., Lo S., Wright K., Liu F., McMahon R.P., Moolchan E.T., Feldman S., Richardson C.M., Wehring H.J., Heishman S.J. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophr. Bull. 2012, 38(3):543-551.
33. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284(20):2606-2610.
34. Levander S., Eberhard J., Lindström E. Nicotine use and its correlates in patients with psychotsis. Acta Psychiatr. Scand. Suppl. 2007, 435:27-32.
35. Levy D.E., Biener L., Rigotti N.A. The natural history of light smokers: a population-based cohort study. Nicotine Tob. Res. 2009, 11(2):156-163.
36. Lising-Enriquez K., George T.P. Treatment of comorbid tobacco use in people with serious mental illness. J. Psychiatry Neurosci. 2009, 34(3):E1-E2.
37. Luoto R., Uutela A., Puska P. Occasional smoking increases total and cardiovascular mortality among men. Nicotine Tob. Res. 2000, 2(2):133-139.
38. Madden P.A., Bucholz K.K., Dinwiddie S.H., Slutske W.S., Bierut L.J., Statham D.J., Dunne M.P., Martin N.G., Heath A.C. Nicotine withdrawal in women. Addiction 1997, 92(7):889-902.
39. Meszaros Z.S., Dimmock J.A., Ploutz-Snyder R.J., Abdul-Malek Y., Leontieva L., Canfield K., Batki S.L. Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Am. J. Addict. 2011, 20:462-467.
40. Moeller-Saxone K. Cigarette smoking and interest in quitting among consumers at a Psychiatric Disability Rehabilitation and Support Service in Victoria. Aust. N. Z. J. Public Health 2008, 32:479-481.
41. Møller A.M., Villebro N., Pedersen T., Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359(9301):114-117.
42. Olivier D., Lubman D.I., Fraser R. Tobacco smoking within psychiatric inpatient settings: a biopsychosocial perspective. Aust. N. Z. J. Psychiatry 2007, 41:572-580.
43. Roick C., Fritz-Wieacker A., Matschinger H., Heider D., Schindler J., Riedel-Heller S., Angermeyer M.C. Health habits of patients with schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42:268-276.
44. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
45. Schane R.E., Glantz S.A., Ling P.M. Social smoking implications for public health, clinical practice, and intervention research. Am. J. Prev. Med. 2009, 37(2):124-131.
46. Schane R.E., Ling P.M., Glantz S.A. Health effects of light and intermittent smoking: a review. Circulation 2010, 121(13):1518-1522.
47. Song Y.M., Cho H.J. Risk of stroke and myocardial infarction after reduction or cessation of cigarette smoking: a cohort study in korean men. Stroke 2008, 39(9):2432-2438.
48. Song Y.M., Sung J., Cho H.J. Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men. J. Clin. Oncol. 2008, 26(31):5101-5106.
49. Strand J.E., Nybäck H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur. Psychiatry 2005, 20(1):50-54.
50. Tidey J.W., Rohsenow D.J., Kaplan G.B., Swift R.M. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob. Res. 2005, 7:421-429.
51. Vanable P.A., Carey M.P., Carey K.B., Maisto S. Smoking among psychiatric outpatients: relationship to substance use, diagnosis and illness severity. Psychol. Addict. Behav. 2003, 17:259-265.
52. Williams J.M., Ziedonis D.M., Abanyie F., Steinberg M.L., Foulds J., Benowitz N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr. Res. 2005, 79(2-3):323-325.
53. Wing V.C., Wass C.E., Soh D.W., George T.P. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann. N. Y. Acad. Sci. 2012, 1248:89-106.
54. Winterer G. Why do patients with schizophrenia smoke?. Curr. Opin. Psychiatry 2010, 23:112-119.
55. Workgroup on substance use disorders, american psychiatric association steering committee on practice guidelines Practice guideline for the treatment of patients with substance use disorders 2006, American Psychiatric Association. 2nd ed.
56. Zhang X.Y., Li C.B., Li M., Zheng Y.L., Zhang C.X., Yan Q.Z., Liu W.Z., Kang Y.M., Wang F., Chen C., Xiu M.H., Kosten T.R. Smoking initiation and schizophrenia: a replication study in a Chinese Han population. Schizophr. Res. 2010, 119(1-3):110-114.
57. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp. Community Psychiatry 1994, 45(3):204-206.
58. Ziedonis D., Histsman B., Beckham J.C., Zvolensky M., Adler L.E., Audrain-McGovern J., Breslau N., Brown R.A., George T.P., Williams J., Calhoun P.S., Riley W.T. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob. Res. 2008, 10(12):1691-1715.